Editorial: ILC checkpoints: expression and functions in physiological and pathological conditions

Editorial: ILC checkpoints: expression and functions in physiological and pathological conditions

Bibliographic Details
Main Authors:	Francesca Romana Mariotti, Nadia Guerra, Ana Stojanovic, Linda Quatrini
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Immunology
Subjects:	innate lymphoid cells natural killer cells activating receptors inhibitory checkpoints cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1220350/full

Similar Items

Specific Patterns of Blood ILCs in Metastatic Melanoma Patients and Their Modulations in Response to Immunotherapy
by: Louise Rethacker, et al.
Published: (2021-03-01)

Immune Checkpoints and Innate Lymphoid Cells—New Avenues for Cancer Immunotherapy
by: Nicolas Jacquelot, et al.
Published: (2021-11-01)

Cancer Immunotherapy by Blocking Immune Checkpoints on Innate Lymphocytes
by: Silvia Pesce, et al.
Published: (2020-11-01)

ILC3: a case of conflicted identity
by: Ivan Koprivica, et al.
Published: (2023-10-01)

Editorial: Innate lymphocytes in tumor surveillance
by: Jörg H. Fritz, et al.
Published: (2022-11-01)

LTα, TNF, and ILC3 in Peyer’s Patch Organogenesis
by: Violetta S. Gogoleva, et al.
Published: (2022-06-01)

The Role of Natural Killer Cells in Soft Tissue Sarcoma: Prospects for Immunotherapy
by: Tânia Fortes-Andrade, et al.
Published: (2021-07-01)

NK Cells and Other Cytotoxic Innate Lymphocytes in Colorectal Cancer Progression and Metastasis
by: Cinzia Fionda, et al.
Published: (2022-07-01)

Killer instincts: natural killer cells as multifactorial cancer immunotherapy
by: Sarah Nersesian, et al.
Published: (2023-11-01)

The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function and Targeting in Tumour Immunotherapy
by: Linda Quatrini, et al.
Published: (2020-11-01)

Editorial: Heterogeneity of ILC2s
by: Hiroki Kabata, et al.
Published: (2023-06-01)

Tissue-resident memory-like ILCs: innate counterparts of TRM cells
by: Xianwei Wang, et al.
Published: (2019-07-01)

EZH1/2 Inhibitors Favor ILC3 Development from Human HSPC-CD34<sup>+</sup> Cells
by: Laura Damele, et al.
Published: (2021-01-01)

Editorial: Therapeutic potential of innate and innate-like effector lymphocytes in autoimmune and inflammatory diseases
by: Lan Wu, et al.
Published: (2023-10-01)

The Tipped Balance of ILC1/ILC2 in Peripheral Blood of Oral Lichen Planus Is Related to Inflammatory Cytokines
by: Zi-Ming Wang, et al.
Published: (2022-01-01)

Development of Type 1 Diabetes in Mice Is Associated with a Decrease in IL-2-Producing ILC3 and FoxP3<sup>+</sup> Treg in the Small Intestine
by: Tamara Saksida, et al.
Published: (2023-04-01)

Hepatitis E Virus Infection—Immune Responses to an Underestimated Global Threat
by: Paul Kupke, et al.
Published: (2021-09-01)

Editorial: The role of immune cells in hepatic ischemia reperfusion
by: Bibo Ke, et al.
Published: (2022-11-01)

Controversial role of ILC3s in intestinal diseases: A novelty perspective on immunotherapy
by: Yunshu Zhang, et al.
Published: (2023-03-01)

Editorial: Innate lymphoid cell development, migration, and function
by: Jorge Henao-Mejía, et al.
Published: (2023-07-01)

The Regulatory Activity of Noncoding RNAs in ILCs
by: Alessio Grimaldi, et al.
Published: (2021-10-01)

Innate Lymphoid Cells: Role in Immune Regulation and Cancer
by: Douglas C. Chung, et al.
Published: (2022-04-01)

Natural Killer Cells and Type 1 Innate Lymphoid Cells in Hepatocellular Carcinoma: Current Knowledge and Future Perspectives
by: Nicolas Jacquelot, et al.
Published: (2021-08-01)

Harnessing NK Cell Checkpoint-Modulating Immunotherapies
by: Sachin Kumar Singh Chauhan, et al.
Published: (2020-07-01)

Harnessing Unconventional T Cells and Innate Lymphoid Cells to Prevent and Treat Hematological Malignancies: Prospects for New Immunotherapy
by: Alessandro Allegra, et al.
Published: (2022-05-01)

ILC2s in skin disorders
by: Yasutomo Imai
Published: (2023-04-01)

Distinct subsets of innate lymphoid cells in nasal polyp
by: Dong Hyun Kim, et al.
Published: (2023-01-01)

Increased regulatory activity of intestinal innate lymphoid cells type 3 (ILC3) prevents experimental autoimmune encephalomyelitis severity
by: Milica Lazarević, et al.
Published: (2024-01-01)

Crossing the valley of death: Toward translational research regarding ILC2
by: Takuya Yashiro, et al.
Published: (2023-04-01)

The role of innate lymphocytes in regulating brain and cognitive function
by: Youwen Si, et al.
Published: (2023-04-01)

TNF Superfamily and ILC2 Activation in Asthma
by: Takahiro Matsuyama, et al.
Published: (2024-02-01)

House Dust Mite Induces Bone Marrow IL-33-Responsive ILC2s and T<sub>H</sub> Cells
by: Emma Boberg, et al.
Published: (2020-05-01)

The Roles of Innate Lymphoid Cells in the Gastric Mucosal Immunology and Oncogenesis of Gastric Cancer
by: Yuhao Jiao, et al.
Published: (2023-04-01)

Efficient and stable CRISPR/Cas9-mediated genome-editing of human type 2 innate lymphoid cells
by: Johanne Audouze-Chaud, et al.
Published: (2023-10-01)

ILC2 regulates hyperoxia-induced lung injury via an enhanced Th17 cell response in the BPD mouse model
by: Yue Zhu, et al.
Published: (2023-05-01)

Cell-Specific Immune Regulation by Glucocorticoids in Murine Models of Infection and Inflammation
by: Lourdes Rocamora-Reverte, et al.
Published: (2022-07-01)

Obesity correlates with the immunosuppressive ILC2s‐MDSCs axis in advanced breast cancer
by: Wei Liu, et al.
Published: (2024-03-01)

ILCs—Crucial Players in Enteric Infectious Diseases
by: Tamara Leupold, et al.
Published: (2022-11-01)

MSI2 deficiency in ILC3s attenuates DSS-induced colitis by affecting the intestinal microbiota
by: Nengneng Li, et al.
Published: (2023-01-01)

Natural Killer Cells: Tumor Surveillance and Signaling
by: Lizeth G. Meza Guzman, et al.
Published: (2020-04-01)